Showing 721-730 of 2123 results for "".
In Review Obstructive Sleep Apnea
https://practicalneurology.com/diseases-diagnoses/sleep/in-review-obstructive-sleep-apnea/30652/Understanding the condition and its effects is essential to patient care.Beyond Altered Mental Status: LOL AMEN
https://practicalneurology.com/columns/practice-management/beyond-altered-mental/30695/A laughably easy test to remember.The Other Kind of Kicking: RLS in Pregnancy
https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-other-kind-of-kicking-rls-in-pregnancy/30744/Women are much more likely to develop RLS after becoming pregnant. Here, specialists discuss how to manage the conditionThe Diagnosis of Functional Movement Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-diagnosis-of-functional-movement-disorder/31884/Functional movement disorder is diagnosed using positive signs, allowing a clinician to “rule-in” the diagnosis.Epilepsy Essentials: Seizure Detection & Prediction
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-seizure-detection-prediction/31819/An Interview With:Lipid Management & Smoking Cessation
https://practicalneurology.com/diseases-diagnoses/stroke/lipid-management-smoking-cessation/31863/High cholesterol and smoking are modifiable factors to prevent secondary stroke.Autoimmune Movement Disorders in Adults
https://practicalneurology.com/diseases-diagnoses/movement-disorders/autoimmune-movement-disorders-in-adults/31702/As antibodies to neuronal targets are described, we see the clinical spectrum and pathophysiology of autoimmune movement disorders more clearly.The Evolution of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-evolution-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/31977/Many individuals with MOGAD may benefit from long-term immunotherapy.Late-Onset Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/late-onset-epilepsy/31945/As the population ages, late-onset epilepsy is becoming a major public health issue with effective treatments and modifiable risk factors.MS Minute: The COVID-19 Vaccine & Vaccine Readiness in MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-the-covid-19-vaccine-vaccine-readiness-in-ms/31748/Evidence suggests all people with multiple sclerosis, including those on any class of disease-modifying treatment, can and should be vaccinated against COVID-19.